Evidence map›Paper›PMID 33810098›Full record

ArticleInternational journal of molecular sciences2021

Transglycosylation Activity of Engineered

Mireia Castejón-Vilatersana, Magda Faijes, Antoni Planas

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Crystal Structure of Glycoside Hydrolase Family 20 Lacto-Journal of applied glycoscience · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mireia Castejón-VilatersanaLaboratory of Biochemistry, Institut Químic de Sarrià, University Ramon Llull, 08017 Barcelona, Spain.ORCID 0000-0002-5568-5153
Magda FaijesLaboratory of Biochemistry, Institut Químic de Sarrià, University Ramon Llull, 08017 Barcelona, Spain.
Antoni PlanasLaboratory of Biochemistry, Institut Químic de Sarrià, University Ramon Llull, 08017 Barcelona, Spain.ORCID 0000-0001-7073-3320
Institut Químic de Sarrià · ES

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2017SGR-727Ministerio de Ciencia e Innovación BFU2016-77427-C2-1-RMinisterio de Ciencia e Innovación PID2019-104350RB-I00
6 · The paper itself

Abstract

The health benefits of human milk oligosaccharides (HMOs) make them attractive targets as supplements for infant formula milks. However, HMO synthesis is still challenging and only two HMOs have been marketed. Engineering glycoside hydrolases into transglycosylases may provide biocatalytic routes to the synthesis of complex oligosaccharides. Lacto-

Indexed as

BifidobacteriumChromatography, High Pressure LiquidEnzyme ActivationGlycoside HydrolasesGlycosylationHumansHydrolysisKineticsMass SpectrometryMilk, HumanModels, MolecularMolecular StructureMutationOligosaccharidesProtein ConformationProtein EngineeringGlycoside Hydrolaseslacto-N-biosidaselacto-N-neotetraoseOligosaccharidesBifidobacteriumbiocatalysishuman milk oligosaccharideslacto-N-biosidaseprotein engineeringtransglycosylation

Identifiers

PMID33810098
PMCPMC8004761
OpenAlexW3138987150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.